| 000 | 01743cam a2200361 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030217.0 | ||
| 008 | 100331s2010 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.19.04.M.Sc.2010.Em.P | ||
| 100 | 0 | _aEmad Eldin Abdealla Shash | |
| 245 | 1 | 0 |
_aPrognostic and predictive markers for hepatocellular carcinoma / _cEmad Eldin Abdealla Shash ; Supervised Heba Mohamed Elzawahry , Magdy Mohamed Saber , Ola Mohamed Reda Khorshid |
| 246 | 1 | 5 | _aالعلامات التكهنيه والتنبؤيه لمرض سرطان الكبد الاولى |
| 260 |
_aCairo : _bEmad Eldin Abdealla Shash , _c2010 |
||
| 300 |
_a146P. : _bcharts; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology (Medical) | ||
| 520 | _aLiver cancer is the 5 {u036D} {u036A} most frequent cancer site among males world wide it constitutes 7.5% of all cancer types l For females it is the 8 {u036D} {u036A} most common accounting for 3.5% of all cancer types . Egyptian Gharbiah population - based cancer registry estimated that liver cancer is 2n {u0369} most frequent cancer site for males after bladder cancer | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBiological markers | |
| 653 | 4 | _aHepatocellular carcinoma | |
| 653 | 4 | _aPrognostic and predictive markers | |
| 700 | 0 |
_aHeba Mohamed Elzawahry , _eSupervisor |
|
| 700 | 0 |
_aMagdy Mohamed Saber , _eSupervisor |
|
| 700 | 0 |
_aOla Mohamed Reda Khorshid , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c29919 _d29919 |
||